Product pipeline
Affitech A/S has built a substantial pipeline of early stage fully human antibody drug candidates using the MBASTM and CBASTM methods, for example targeting VEGF (Vascular Endothelial Growth Factor) and GPCR (G-protein coupled receptors).
Affitech A/S has built a substantial pipeline of early stage fully human antibody drug candidates using the MBASTM and CBASTM methods, for example targeting VEGF (Vascular Endothelial Growth Factor) and GPCR (G-protein coupled receptors).
